Pancreatic cancer reprograms nerve cells to fuel its growth, but blocking these connections can shrink tumors and boost ...

The data show that up to 80% of people who are diagnosed with pancreatic cancer have either recently developed Type 2 diabetes or have prediabetes.

Glucagon-like peptide 1 (GLP-1) drugs, such as Ozempic, are intended for type 2 diabetes patients and people with obesity, ...

Pancreatic cancer is the 10th deadliest form of cancer in the United States, according to the National Cancer Institute.

A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease ...

The discovery of the hormone insulin and its subsequent production since the 1920s has saved the lives of millions of diabetes sufferers. Insulin mediates the transfer of glucose – i.e. blood sugar, ...

Mitochondrial stress disrupts insulin production in diabetes, but reversing the damage may restore β-cell function.

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

Researchers at the University of Michigan have identified how mitochondrial dysfunction impairs insulin-producing pancreatic ...

A personalized mRNA vaccine may reduce the risks of pancreatic cancer returning after surgery, according to a preliminary ...